Avat Xavier 4
4 · CAPRICOR THERAPEUTICS, INC. · Filed May 26, 2022
Insider Transaction Report
Form 4
Avat Xavier
CHIEF BUSINESS OFFICER
Transactions
- Award
Stock Option (Right to Buy)
2022-05-23+370,000→ 370,000 totalExercise: $3.46Exp: 2032-05-23→ Common Stock (370,000 underlying)
Footnotes (1)
- [F1]The shares vest 1/48th of the first day of each month, commencing June 1, 2022, until the stock option becomes fully vested and exercisable. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting.